Main Article Content

Abstract

The present study was aimed efficiency to evaluate the unsaturated fatty acid omega-3 in reducing the side effects that resulted from administration of cyclosporine drug in white New Zealand rabbits. (60) from white males' rabbits were used in this study, the animals divided into major four groups (15) rabbits per group and its subdivision into three groups (5) rabbits per group. The first group is orally administered with normal saline, second groups were administered cyclosporine (25mg/kg) only. Third groups were administered cyclosporine (25mg/kg) in the first day and Omega-3 (500mg/kg) in the second day, while Fourth groups were administered cyclosporine (25mg/kg) in the first day and omega-3 (1000mg/kg) in the second day for periods (21,30,60) days respectively. After ending study periods, the animals were sacrificed and the blood was collected and samples from liver were taken and the results were showed the following: the histological study showed pathological changes after administration of cyclosporine (25mg/kg) with blood congestion for period (21day), while severe blood congestion with beginning of fibrosis for period (30day) while in the period (60day) very severe blood congestion with aggregation of inflammatory cells and grow of fibroblast cells were showed. while the interaction between cyclosporine and two concentrations (500&1000mg/kg) of omega-3 were showed non-pathological changes in liver tissues. From this study concluded that omega-3 have an important role in the reducing histopathology side effects that result from administration of cyclosporine drug in white rabbits.

Keywords

Omega-3 Cyclosporine Drug Liver Inflammatory Cells Fibroblast Cells

Article Details

How to Cite
Jawad, M. M., & Al-Kraity, W. R. H. (2021). Effect Of Unsaturated Fatty Acid Omega-3 On Some Histological Criteria In White New Zealand Rabbits Administrated With Cyclosporine Drug. Medical Science Journal for Advance Research, 2(3), 95–101. https://doi.org/10.46966/msjar.v2i3.28

References

  1. K. E. Bushley et al., “The Genome of Tolypocladium inflatum: Evolution, Organization, and Expression of the Cyclosporin Biosynthetic Gene Cluster,” PLoS Genet., 2013, doi: 10.1371/journal.pgen.1003496.
  2. G. S. Baarsma and L. Caspers, “Cyclosporin A,” in Intraocular Inflammation, 2016.
  3. S. Nkongolo et al., “Cyclosporin A inhibits hepatitis B and hepatitis D virus entry by cyclophilin-independent interference with the NTCP receptor,” J. Hepatol., 2014, doi: 10.1016/j.jhep.2013.11.022.
  4. A. H. de Wilde et al., “Cyclosporin A inhibits the replication of diverse coronaviruses,” J. Gen. Virol., 2011, doi: 10.1099/vir.0.034983-0.
  5. D. Stevenson, J. Tauber, and B. L. Reis, “Efficacy and safety of cyclosporin A ophthalmic emulsion in the treatment of moderate-to-servere dry eye disease: A dose-ranging, randomized trial,” Ophthalmology, 2000, doi: 10.1016/S0161-6420(00)00035-X.
  6. C. Emilienne Soma, C. Dubernet, D. Bentolila, S. Benita, and P. Couvreur, “Reversion of multidrug resistance by co-encapsulation of doxorubicin and cyclosporin A in polyalkylcyanoacrylate nanoparticles,” Biomaterials, 2000, doi: 10.1016/S0142-9612(99)00125-8.
  7. W. Y. Lim, C. M. Messow, and C. Berry, “Cyclosporin variably and inconsistently reduces infarct size in experimental models of reperfused myocardial infarction: A systematic review and meta-analysis,” British Journal of Pharmacology. 2012, doi: 10.1111/j.1476-5381.2011.01691.x.
  8. A. P. Simopoulos, “The importance of the ratio of omega-6/omega-3 essential fatty acids,” Biomed. Pharmacother., 2002, doi: 10.1016/S0753-3322(02)00253-6.
  9. B. Cassileth, “Omega-3,” Oncology, 2010, doi: 10.18508/endo2991.
  10. A. P. Simopoulos, “Omega-3 fatty acids in inflammation and autoimmune diseases,” J. Am. Coll. Nutr., 2002, doi: 10.1080/07315724.2002.10719248.
  11. A. P. Simopoulos, “Evolutionary aspects of diet: The omega-6/omega-3 ratio and the brain,” Mol. Neurobiol., 2011, doi: 10.1007/s12035-010-8162-0.
  12. A. Gupta, C. J. Barrow, and M. Puri, “Omega-3 biotechnology: Thraustochytrids as a novel source of omega-3 oils,” Biotechnology Advances. 2012, doi: 10.1016/j.biotechadv.2012.02.014.
  13. P. C. Calder, “Omega-3 fatty acids and inflammatory processes,” Nutrients. 2010, doi: 10.3390/nu2030355.
  14. A. P. DeFilippis and L. S. Sperling, “Understanding omega-3’s,” American Heart Journal. 2006, doi: 10.1016/j.ahj.2005.03.051.
  15. T. C. Adarme-Vega, D. K. Y. Lim, M. Timmins, F. Vernen, Y. Li, and P. M. Schenk, “Microalgal biofactories: a promising approach towards sustainable omega-3 fatty acid production,” Microbial Cell Factories. 2012, doi: 10.1186/1475-2859-11-96.
  16. M. M. Jawad, “Effect of Unsaturated Fatty Acid Omega-3 on Some Biochemical Criteria in White New Zealand Rabbits Administrated with Cyclosporine Drug,” Med. Sci. J. Adv. Res., vol. 2, no. 1, pp. 15–24, 2021, doi: 10.46966/msjar.v2i1.14.
  17. M. M. Jawad, “Relationship Between Hepatotoxicity That Induced by CCL4 and Regucalcin Protein Marker,” Med. Sci. J. Adv. Res., vol. 2, no. 2, pp. 35–44, 2021, doi: 10.46966/msjar.v2i2.17.
  18. D. A. Levison, “Book Reviews :Theory and practice of histological techniques. 4th Edition. JOHND. BANCROFT and ALAN STEVENS. Churchill Livingstone, Edinburgh. 1996 No. of Pages: 766 Price £79.50,” J. Pathol., 1997, doi: 10.1002/(sici)1096-9896(199710)183:2<243::aid-path770>3.0.co;2-f.
  19. J. Stull, “SPSS for Windows,” Teach. Sociol., 1994, doi: 10.2307/1318629.
  20. D. Phillips, A. R. Deipolyi, R. L. Hesketh, M. Midia, and R. Oklu, “Pelvic congestion syndrome: Etiology of pain, diagnosis, and clinical management,” Journal of Vascular and Interventional Radiology. 2014, doi: 10.1016/j.jvir.2014.01.030.
  21. F. Tacke, T. Luedde, and C. Trautwein, “Inflammatory pathways in liver homeostasis and liver injury,” Clinical Reviews in Allergy and Immunology. 2009, doi: 10.1007/s12016-008-8091-0.
  22. A. Hoshino et al., “Tumour exosome integrins determine organotropic metastasis,” Nature, 2015, doi: 10.1038/nature15756.
  23. F. Heymann and F. Tacke, “Immunology in the liver-from homeostasis to disease,” Nature Reviews Gastroenterology and Hepatology. 2016, doi: 10.1038/nrgastro.2015.200.
  24. A. Ayala, M. F. Muñoz, and S. Argüelles, “Lipid peroxidation: Production, metabolism, and signaling mechanisms of malondialdehyde and 4-hydroxy-2-nonenal,” Oxidative Medicine and Cellular Longevity. 2014, doi: 10.1155/2014/360438.
  25. C. Mylonas and D. Kouretas, “Lipid peroxidation and tissue damage,” In Vivo. 1999.
  26. T. P. A. Devasagayam, K. K. Boloor, and T. Ramasarma, “Methods for estimating lipid peroxidation: An analysis of merits and demerits,” Indian Journal of Biochemistry and Biophysics. 2003.
  27. Y. Xie et al., “Ferroptosis: Process and function,” Cell Death and Differentiation. 2016, doi: 10.1038/cdd.2015.158.
  28. G. Silling, “Fluconazole: optimized antifungal therapy based on pharmacokinetics.,” Mycoses. 2002, doi: 10.1111/j.1439-0507.2002.tb04768.x.
  29. G. Bayramoglu, B. Filiz Senkal, M. Yilmaz, and M. Yakup Arica, “Immobilization and stabilization of papain on poly(hydroxyethyl methacrylate-ethylenglycol dimethacrylate) beads grafted with epoxy functional polymer chains via surface-initiated-atom transfer radical polymerization (SI-ATRP),” Bioresour. Technol., 2011, doi: 10.1016/j.biortech.2011.08.042.
  30. D. Domaradzka, U. Guzik, and D. Wojcieszyńska, “Biodegradation and biotransformation of polycyclic non-steroidal anti-inflammatory drugs,” Reviews in Environmental Science and Biotechnology. 2015, doi: 10.1007/s11157-015-9364-8.
  31. G. M. Cole, Q. L. Ma, and S. A. Frautschy, “Omega-3 fatty acids and dementia,” Prostaglandins Leukot. Essent. Fat. Acids, 2009, doi: 10.1016/j.plefa.2009.05.015.
  32. S. S. Gill and N. Tuteja, “Reactive oxygen species and antioxidant machinery in abiotic stress tolerance in crop plants,” Plant Physiology and Biochemistry. 2010, doi: 10.1016/j.plaphy.2010.08.016.
  33. T. Dodd-Butera and M. Broderick, “Cyclosporine,” in Encyclopedia of Toxicology: Third Edition, 2014.
  34. N. Rubio-Rodríguez, S. Beltrán, I. Jaime, S. M. de Diego, M. T. Sanz, and J. R. Carballido, “Production of omega-3 polyunsaturated fatty acid concentrates: A review,” Innovative Food Science and Emerging Technologies. 2010, doi: 10.1016/j.ifset.2009.10.006.